These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19945236)

  • 1. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteal support: progestogens for pregnancy protection.
    Daya S
    Maturitas; 2009 Dec; 65 Suppl 1():S29-34. PubMed ID: 19913373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
    Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
    Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
    BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
    Kuptarak A; Phupong V
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of dydrogesterone for the treatment of threatened miscarriage.
    Carp H
    Gynecol Endocrinol; 2012 Dec; 28(12):983-90. PubMed ID: 22794306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind controlled trial of progesterone substitution in threatened abortion.
    Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy.
    Yuen BH; Livingston JE; Poland BJ; Wittmann BK; Sy L; Cannon W
    Obstet Gynecol; 1981 Feb; 57(2):207-14. PubMed ID: 7465126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human chorionic gonadotrophin for threatened miscarriage.
    Devaseelan P; Fogarty PP; Regan L
    Cochrane Database Syst Rev; 2010 May; (5):CD007422. PubMed ID: 20464754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
    Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
    BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies.
    Gracia CR; Sammel MD; Chittams J; Hummel AC; Shaunik A; Barnhart KT
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):993-9. PubMed ID: 16260517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current role of progesterone therapy in the prevention of spontaneous abortion and in the treatment of threatened abortion].
    Marzetti L; Boni T; Fazzio M; Giobbe M
    Minerva Ginecol; 2000 Dec; 52(12):515-9. PubMed ID: 11310149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dydrogesterone in threatened abortion: pregnancy outcome.
    Omar MH; Mashita MK; Lim PS; Jamil MA
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.